Provectus Biopharmaceuticals, Inc. (PVCT)

PVCT Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	52	40	45	22	23	24
Market Cap Growth	15.22%	-11.35%	102.33%	-1.56%	-6.35%	27.40%
Enterprise Value	55	42	48	24	47	44
PE Ratio	-	-12.98	-12.78	-3.45	-2.71	-2.91
PS Ratio	88.41	72.21	45.93	-	-	-
PB Ratio	-10.71	-5.30	-7.29	-5.36	-0.76	-1.01
P/FCF Ratio	-26.65	-15.66	-14.94	-22.16	-5.58	-3.93
P/OCF Ratio	-26.65	-15.66	-14.94	-22.16	-5.58	-3.93
EV/Sales Ratio	92.53	75.80	48.12	-	-	-
EV/EBITDA Ratio	-33.84	-14.49	-14.08	-5.09	-9.92	-8.09
EV/EBIT Ratio	-33.72	-14.45	-14.03	-5.07	-9.44	-7.19
EV/FCF Ratio	-27.46	-16.44	-15.65	-23.20	-11.38	-7.13
Debt / Equity Ratio	-0.43	-0.40	-0.35	-0.42	-0.79	-0.85
Debt / EBITDA Ratio	-1.32	-1.04	-0.65	-0.38	-5.08	-3.73
Debt / FCF Ratio	-1.07	-1.18	-0.72	-1.72	-5.82	-3.29
Quick Ratio	0.09	0.11	0.00	0.09	0.00	0.21
Current Ratio	0.12	0.15	0.23	0.45	0.01	0.33
Asset Turnover	0.44	0.38	0.49	0	0	0
Interest Coverage	-4.77	13.53	-20.94	-4.86	-2.84	-4.33
Return on Equity (ROE)	37.30%	40.85%	57.06%	155.26%	27.89%	34.80%
Return on Assets (ROA)	-257.50%	-214.09%	-174.46%	-185.04%	-1430.02%	-567.24%
Return on Capital (ROIC)	57.62%	64.05%	84.77%	191.23%	77.44%	170.35%
Earnings Yield	-5.32%	-7.70%	-7.82%	-28.96%	-36.94%	-34.40%
FCF Yield	-5.73%	-6.39%	-6.70%	-4.51%	-17.91%	-25.42%
Buyback Yield / Dilution	-0.01%	-0.01%	-2.76%	-3.81%	-1.72%	-1.11%
Total Shareholder Return	-0.01%	-0.01%	-2.76%	-3.81%	-1.72%	-1.11%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.